See All Product Strategies
As part of the research for the feature story, “A Change of Course for Pharma Manufacturing,” which appears in the June 2009 issue of Automation World, Managing Editor Wes Iversen recently interviewed Dr. Moheb Nasr, Director of the Office of New Drug Quality Assessment, Center for Drug Evaluation and Research, at the U.S. Food and Drug Administration.
During the interview, Dr. Nasr discusses the FDA’s Quality by Design initiative, the Agency’s regulatory approach and industry’s response to date.
